Active Postmarketing Drug Surveillance for Multiple Adverse Events
From MaRDI portal
Publication:2797469
DOI10.1287/OPRE.2015.1435zbMath1347.62228OpenAlexW85697195MaRDI QIDQ2797469
Mohsen Bayati, Stefanos A. Zenios, Joel Weiqiang Goh, Margrét V. Bjarnadóttir
Publication date: 5 April 2016
Published in: Operations Research (Search for Journal in Brave)
Full work available at URL: https://semanticscholar.org/paper/a76ca550531b66458809387be4c370051ff0b21f
Uses Software
Cites Work
- Unnamed Item
- A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance
- Solving semidefinite-quadratic-linear programs using SDPT3
- Sequential analysis. Tests and confidence intervals
- Networks of infinite-server queues with nonstationary Poisson input
- Power, sample size and adaptation considerations in the design of group sequential clinical trials
- The Physics of the Mt/G/∞ Queue
- SDPT3 — A Matlab software package for semidefinite programming, Version 1.3
- Optimum Character of the Sequential Probability Ratio Test
- Sequential Tests of Statistical Hypotheses
This page was built for publication: Active Postmarketing Drug Surveillance for Multiple Adverse Events